INTERNATIONAL OPHTHALMOLOGY, vol.38, no.3, pp.1021-1025, 2018 (SCI-Expanded)
To evaluate the whether intravitreal erythropoietin (EPO) administration has any beneficial or adverse effect in patients with late-stage optic neuropathy (ON) or not.